← FDA Drug Approvals (Drugs@FDA)
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2022-10-31
Drug application
- FDA Application #
ANDA091086- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Generic name
- Brimonidine Tartrate
- Active ingredients
- BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- SENTISS
- First approval
- 2022-10-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown